The purpose of the study is to compare surrogate estimates of insulin sensitivity with a directly measured insulin sensitivity index, steady-state plasma glucose (SSPG) from insulin suppression test (IST), in subjects with hypertension. Two hundred and twenty-eight hypertensive patients who received IST for SSPG were included for analysis. Estimates from fasting measurements alone, homeostasis model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI)), and indices from fasting and/or 2 h samples (ISI 0,120 and ISI TX ) were calculated. In addition to Pearson and partial correlations, variancecomponent models were used to test the relationship between surrogate estimates of insulin sensitivity and SSPG. A large proportion of variance owing to covariates in the variance-component models indicated the goodness of model fit, irrespective of the independence among variables. SSPG was positively correlated with logarithmic transformation (Log) (HOMA-IR) and negatively correlated with QUICKI, Log (ISI 0,120 ) and ISI TX (all Po0.0001). Log (ISI 0,120 ) seemed to have a better correlation with SSPG (r ¼ À0.72) than other measures in partial correlation. The proportion of variance owing to all covariates of Log (ISI 0,120 ) and ISI TX were larger than those of Log (HOMA-IR) and QUICKI in the variancecomponent models. After adjustments for demographic and obesity covariates, the proportion of variance explained by Log (ISI 0,120 ) were largest among the surrogate measures in the variance-component models. Our results showed that ISI 0,120 and ISI TX correlated better with SSPG than those used fasting measures alone (HOMA-IR and QUICKI). Log (ISI 0,120 ) currently showing the strongest association with SSPG than other estimates is adaptable for use in large studies of hypertension.
Introduction
New-onset diabetes is an important clinical problem that occurs in nearly 2% of treated hypertensive subjects a year. 1 The occurrence of new diabetes in nondiabetic hypertensive subjects during treatment portended a threefold risk for subsequent cardiovascular disease than those who remained free of diabetes. 1 It has been suggested that insulin resistance is a major determinant in the transition from normal to diabetes. 2 3 emphasized that insulin resistance and its manifestations might play important roles in the development of cardiovascular diseases in patients with hypertension. In vivo insulin resistance can be measured directly by sophisticate metabolic tests like glucose clamp techniques and insulin suppression tests (IST). 4 However, direct measurements of insulin sensitivity are frequently expensive, procedure-demanding and time-consuming. 4 For large clinical studies of hypertension and insulin resistance, sometimes surrogate measures of insulin sensitivity are the only option.
Reaven
Several surrogate estimates based on fasting levels of glucose and insulin including the homoeostasis model assessment for insulin resistance (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI) have been reported to be good indices of insulin sensitivity for hypertension. 5, 6 Nevertheless, in an earlier study by Ferrannini et al., 7 the investigators suggested that insulin resistance in hypertension involved with pathways of insulinstimulated glucose uptake. Yeni-Komshian et al. 8 found that insulin-mediated glucose disposal, measured directly by steady-state plasma glucose (SSPG) from IST, was best represented by an integrated response to oral glucose challenges. Abbasi and Reaven 9 have compared QUICKI and HOMA-IR with SSPG and revealed that both of them had limitations in explanation of the variability of SSPG.
Hjelmesaeth et al. 10 have proposed an insulin sensitivity index, ISI TX , incorporating postchallenge glucose and insulin levels to estimate insulin sensitivity and reported a close correlation between ISI TX and glucose clamp results. Gutt et al. 11 proposed an index of insulin sensitivity (ISI 0,120 ) composed from both fasting and 2 h measures of glucose and insulin and demonstrated that the index correlated well with directly measured insulin sensitivity. Yet, there is sparse evidence to support the concept of indices integrating postchallenge values surrogated insulin sensitivity better than HOMA-IR and QUICKI for subjects with hypertension. In the current study, we use SSPG as a reference to compare the performance of the above four surrogates to estimate insulin-mediated glucose uptake in a cohort consisting entirely of hypertensive subjects. We hypothesized that indices with information from fasting and/or postchallenge measurements provide better estimation of insulin resistance than measures using fasting data alone for subjects with hypertension.
Materials and methods

Subjects
The study is a part of the SAPPHIRe, a multi-centre effort to recruit hypertensive patients and their siblings for a genetic study of hypertension in Chinese and Asian Americans. The study population has been reported previously. 12, 13 The SAPPHIRe Network consists of six field centres in San Francisco, Hawaii and Taiwan. In the present study, 228 (119 men, 109 women) hypertensive patients who received IST to evaluate their in vivo insulin sensitivity were included for analysis. The hypertensive patients were between 35 and 60 years old and without other health problems.
14 All participants with known history of diabetes and fasting plasma glucose (PG) X7.0 mmol/l were excluded from the study. Their serum creatinine levels were below 133 mmol/l. Very obese subjects with a body mass index (BMI) greater than 35 kg/m 2 were excluded. 15 The Institutional Review Board from each centre approved the study protocol and each participant gave written informed consent before entering the study.
Clinical examination
The participants received anthropometric measurements at 08 AM after 10 h overnight fasting. Body weight (BW) was measured to the nearest 0.1 kg. Body height (BH) was measured to the nearest millimetre by stadiometers. BMI was calculated as BW divided by BH 2 (kg/m 2 ). Waist circumference (WC) was measured at the level of umbilicus to the nearest millimetre. Sitting blood pressure (BP) was measured by an automated oscillometric BP recorder (Dinamap 1864SX, Critikon, Tampa, FL, USA) according to a protocol described earlier. 12 Each subject was subjected to a 75 g oral glucose tolerance test (OGTT) thereafter. 13 Fasting blood samples were collected for the measurements of PG and insulin. Then, 75 g glucose monohydrate (in 300 ml water) was administered to the subject to drink off within 5 min. Blood samples were taken for PG and insulin 120 min after glucose loading. The patients were not allowed to eat or drink until the end of the test. Standardized interview-administered questionnaires were used during the OGTT to obtain information on demographic characteristics. 16 On a separate visit, within 3-7 days of the first visit, the participants underwent an IST to assess their in vivo insulin sensitivity after a 10 h overnight fasting according to the procedures reported earlier. 17 All subjects were infused with regular insulin (Humulin-R, Lilly, IN, USA; 25 mU/min-m 2 ) and glucose (TAIYU, Shin-Tzu, Taiwan; 240 mg/min-m 2 ) simultaneously for 180 min with infusion pumps (Harvard Apparatus, Boston, MA, USA). In addition, somatostatin (5 mg/min) (Somatosan, Ferring, Switzerland) was infused intravenously over the same period of time. The mean values of PG at 150, 160, 170 and 180 min during the IST were defined as SSPG that represented in vivo insulin sensitivity of the subjects.
Computation of surrogate indices
The following were chosen as surrogate indices of insulin sensitivity.
HOMA-IR was calculated by the simplified formula reported by Maththews et al. QUICKI was calculated by a formula reported by Katz et al.
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QUICKI ¼1=½Log ðFasting insulin ðmU=mlÞÞ þ LogðFasting PG ðmg=dlÞÞ ð2Þ ISI 0,120 was derived from a formula reported by Gutt et al. The variance-component models included SSPG as the dependent variable and each of the surrogate measures as the independent variables with or without adjustments of demographic covariates (age, sex, field centres, education levels, physical activity, smoking, drinking and family). These models were then re-used including the demographic covariates and obesity indicators (WC and BMI) to examine the relative effects of obesity on the correlations between SSPG and surrogate measures of insulin sensitivity. Estimates and proportion of variance owing to all covariates were obtained from the results of the variancecomponent modelling. A large proportion of variance owing to all covariates indicated the goodness of model fit. A P-value o0.05 was considered to be statistically significant.
Results
The clinical characteristics of the study participants are shown in Table 1 ISI TX , before and after adjustments for demographic variables (including age, sex, field centres, education levels, physical activity, smoking, drinking and family ) (all Po0.0001). Log (ISI 0,120 ) seems to have a better correlation with SSPG (r ¼ À0.72) than other surrogate measures in partial correlation (Table 3) . The results from the variance-component models affirm the above relationship in these subjects, irrespective of the independences among variables ( Table 4 ). The proportion of variance owing to all covariates of Log (ISI 0,120 ) and ISI TX were larger than those of Log (HOMA-IR) and QUICKI before and after adjustments for confounding factors. The proportion of variance owing to all covariates of Log (ISI 0,120 ) was largest among the surrogate measures in the variance-component models after adjustments for demographic and obesity variables.
Discussion
HOMA-IR and QUICKI have been claimed to be useful surrogate measures of insulin resistance for hypertension. 5, 6 However, HOMA-IR and QUICKI are markers that assess insulin resistance in the fasting state rather than in the postprandial state, and they tend to represent hepatic rather than peripheral insulin resistance. 21 Ferrannini et al. 7 previously revealed that insulin-mediated glucose uptake was reduced by 40% in subjects with hypertension. The investigators suggested that peripheral tissues (mainly muscle), and not the liver, seemed to be a major site of insulin resistance in hypertension. Although changes in hepatic insulin sensitivity parallel with changes in peripheral insulin sensitivity frequently, 22 Matsuda and DeFronzo. 21 have reported that there were a significant number of individuals with normal or near-normal hepatic insulin sensitivity but impaired peripheral insulin sensitivity. The observation raises concern about the use of measures based on fasting samples alone (such as HOMA and QUICKI) to provide a reasonable approximation of insulin resistance in hypertension because the assumption of the fasting models was that hepatic and peripheral insulin sensitivity are equivalent. 18, 19 Our results clearly showed that estimates incorporating information of postchallenge data (ISI 0,120 and ISI TX ) correlated better with the directly measured insulin resistance than those that used fasting data alone in hypertension (Tables 3 and 4 ). Chen et al. 6 reported a slightly better correlation between QUICKI and insulin sensitivity index from clamps (r ¼ 0.84) than that between HOMA-IR and clamps (r ¼ À0.76) in a study with only 27 hypertensive subjects. The correlation between QUICKI and Log (HOMA-IR) was almost perfect (r ¼ À0.99, Po0.0001) in the current study. Not surprisingly, we were not able to demonstrate the superiority of using QUICKI 19 as a surrogate measure of insulin resistance as compared with using HOMA-IR for hypertension (Tables 3 and  4) . Given the results in this study, we suggest that values from glucose challenge should be included to surrogate insulin sensitivity for hypertension when an OGTT is possible.
The ISI 0,120 is a more complex assessment of insulin resistance. 11 The index derives from a function of BW and fasting and 2 h insulin and glucose (equation (3)). It directly assesses total 
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; Log (HOMA-IR), log transformation of HOMA-IR; Log (ISI 0,120 ), log transformation of ISI 0,120 ; QUICKI, quantitative insulin sensitivity check index. Data are expressed as estimate (proportion of variance owing to all covariates). The variance-component models were used as alternative statistical methods to test the relation between SSPG and insulin sensitivity indices, irrespective of the independence among variables tested. Please refer to the text for details of the variance-component models. The larger proportion of variance owing to all covariates indicates the better goodness of fit. a The demographic variables include age, sex, field centers, education levels, physical activity, smoking, drinking and family. ***Po0.0001. body's response to glucose loading and accounts more for peripheral insulin resistance and glucose disposal. 11, 23 Earlier studies have shown that the index predicted future development of diabetes and cardiovascular events. Hanley et al. 24 compared the ability of surrogate estimates of insulin resistance to predict diabetes using combined prospective data from three large population studies. The investigators found that ISI 0,120 displayed the largest (78%) area under the receiver operator characteristic (ROC) curves and was significantly more predictive (Po0.0001) than other indices whereas HOMA-IR only covered 62.8% and QUICKI 71.5% area under the ROC curves. 24 Rutter et al. 23 found that ISI 0,120 , but not HOMA-IR, independently predicted incident cardiovascular events in the Framingham Offspring Study. These differences seem to reflect a fact that ISI 0,120 may capture more important domains related to the development of diabetes and cardiovascular disease including peripheral insulin resistance, hepatic insulin resistance, glucose disposal and b-cell dysfunction versus those that use fasting measures alone. 11, 23 Technically, only one postloading sampling is needed for the calculation of ISI 0,120 . Moreover, the 2 h PG values not only apply to the calculation of ISI 0,120 but also help to make diagnosis of oral glucose tolerance for the participants. Therefore, we propose to use this index than other OGTTbased estimates of insulin sensitivity that require more samplings or longer procedure time 8, 21 in large clinical studies of hypertension and insulin resistance.
Kim et al. 25 declared that the degree of obesity had impact on the relationship between SSPG and surrogate estimates of insulin resistance. In the present study, we used variance-component models to examine the roles of WC and BMI on the relations between surrogate estimates and SSPG, irrespective of the independence among variables. The ranking of correlation of the indices maintained almost the same order before and after adjustments for WC and BMI (Table 4) . Our results showed that the influence of obesity on the performance of estimates to surrogate SSPG in this study was insignificant.
Stumvoll et al. 26 used multiple linear regression techniques to subject demographic variables and values from the OGTT to predict insulin sensitivity obtained from glucose clamps. The insulin sensitivity index (ISI STUMOD ) was highly correlated with directly measured insulin sensitivity. 26 However, it needs both 90-min postloading glucose and 2 h insulin values to calculate the ISI STUMO . Hjelmesaeth et al. 10 have demonstrated that when 2 h glucose (instead of 90-min glucose) was used for the calculation, the ISI STUMOD would overestimate the clamp-measured insulin sensitivity. The authors adjusted the Stumvoll equation and derived the insulin sensitivity index (ISI TX ) from the original ISI STUMOD . The ISI TX is a function of BMI, 2 h insulin and 2 h PG (equation (4)) and correlated well with glucose clamp results. We used the index in this study as an estimate of insulin sensitivity from postloading values and compared the performance of ISI TX with Log (ISI 0,120 ). Our data showed that the correlation between ISI TX and SSPG was as good as that between Log (ISI 0,120 ) and SSPG (Tables 3 and  4) . The results provided an alternative approach to emphasize the importance of incorporating information of post-glucose loading values for the estimates of insulin-mediated glucose uptake.
There are limitations to our study. We do not have data of intraindividual variation of ISI 0,120 . Mooy et al. 27 have identified a substantial intraindividual variation in 2-h glucose and insulin (around 20%) in subjects with different glucose tolerance. This is clearly an important consideration before implementation of ISI 0,120 into large clinical studies. The present study also does not have sufficient numbers of subjects to compare the antihypertensive treatment effects on surrogate measures of insulin resistance and SSPG. We have reported previously the influences of b-blockers and diuretics on insulin resistance in hypertensive subjects. 28 More than 300 hypertensive subjects from the SAPPHIRe cohort were included in that analysis. Hypertensive patients who were taking b-blockers and/or diuretics showed no difference in fasting glucose and insulin, 2-h glucose and insulin, and HOMA-IR values as compared with those not taking b-blockers and/or diuretics. Because of the complexity of concomitant use of antihypertensive agents in the study subjects, we are very cautious in performing sub-group analysis in the present study because of the smaller sample size.
In conclusion, we demonstrated that surrogate estimates with information from oral glucose challenge (ISI 0,120 and ISI TX ) correlated better with directly measured insulin sensitivity for subjects with hypertension than those that used fasting measures alone (HOMA-IR and QUICKI). Log (ISI 0,120 ) currently showing a better association with SSPG than other estimates is adaptable for use in large clinical studies of hypertension.
What is known on the topic K Peripheral tissue (mainly muscle), and not the liver, appears to be a major site involved with insulin resistance in hypertension. K Although estimates based on fasting samples (HOMA-IR and QUICKI) tend to represent hepatic rather than peripheral insulin sensitivity, they have been claimed to surrogate insulin resistance well in hypertension. K There is sparse evidence to compare the performance of surrogate estimates from fasting and/or postchallenge measurements for insulin resistance in a cohort totally consisting of hypertensive subjects.
What this study adds K Values from glucose challenge should be included to surrogate insulin sensitivity for hypertension when an oral glucose tolerance test is possible. K Insulin sensitivity index ISI 0,120 was recommended to be a better estimate of insulin sensitivity than HOMR-IR and QUICKI in subjects with hypertension.
